JBC Advanced Glycation Endproducts

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.M402032200 on April 15, 2004

J. Biol. Chem., Vol. 279, Issue 25, 26266-26273, June 18, 2004
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
279/25/26266    most recent
M402032200v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Oury, C.
Right arrow Articles by Hoylaerts, M. F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Oury, C.
Right arrow Articles by Hoylaerts, M. F.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

ATP Augments von Willebrand Factor-dependent Shear-induced Platelet Aggregation through Ca2+-Calmodulin and Myosin Light Chain Kinase Activation*

Cécile Oury{ddagger}§, Elsie Sticker{ddagger}, Heidi Cornelissen{ddagger}, Rita De Vos¶, Jos Vermylen{ddagger}, and Marc F. Hoylaerts{ddagger}||

From the {ddagger}Center for Molecular and Vascular Biology and the Laboratory of Morphology and Molecular Pathology, University of Leuven, 3000 Leuven, Belgium

Shear stress triggers von Willebrand factor (VWF) binding to platelet glycoprotein Ib{alpha} and subsequent integrin {alpha}IIb{beta}3-dependent platelet aggregation. Concomitantly, nucleotides are released from plateletdense granules, and ADP is known to contribute to shear-induced platelet aggregation (SIPA). We found that the impaired SIPA of platelets from a Hermansky-Pudlak patient lacking dense granules was restored by exogenous L-{beta},{gamma}-methylene ATP, a stable P2X1 agonist, as well as by ADP, confirming that in addition to ADP (via P2Y1 and P2Y12), ATP (via P2X1) also contributes to SIPA. Likewise, SIPA of apyrase-treated platelets was restored upon P2X1 activation with L-{beta},{gamma}-methylene ATP, which promoted granule centralization within platelets and stimulated P-selectin expression, which is a marker of {alpha}-granule release. In addition, during SIPA, platelet degranulation required both extracellular Ca2+ and VWF-glycoprotein Ib{alpha} interactions without involving {alpha}IIb{beta}3. Neither platelet release nor SIPA was affected by protein kinase C inactivation, even though protein kinase C blockade inhibits platelet responses to collagen and thrombin in stirring conditions. In contrast, inhibiting myosin light chain (MLC) kinase with ML-7 reduced platelet release and SIPA by 30%. Accordingly, the potentiating effect of P2X1 stimulation on the aggregation of apyrase-treated platelets coincided with intensified phosphorylation of MLC and was abrogated by ML-7. SIPA-induced MLC phosphorylation occurred exclusively through released nucleotides and selective antagonism of P2X1 with MRS2159-reduced SIPA, ATP release, and potently inhibited MLC phosphorylation. We conclude that the P2X1 ion channel induces MLC-mediated cytoskeletal rearrangements, thus contributing to SIPA and degranulation during VWF-triggered platelet activation.


Received for publication, February 24, 2004 , and in revised form, April 14, 2004.

* This work was supported by Fonds voor Wetenschappelijk Onderzoek-Vlaanderen (FWO) Project G.0227.03 and by Geconcerteerde Onderzoeksactie/2004/09. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

§ Recipient of a postdoctoral research mandate from the FWO.

|| To whom correspondence should be addressed: University of Leuven, Center for Molecular and Vascular Biology, Herestraat 49, 3000 Leuven, Belgium. Tel.: 32-16-346145; Fax: 32-16-345990; E-mail: marc.hoylaerts{at}med.kuleuven.ac.be.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
C. Vial and R. J. Evans
Disruption of Lipid Rafts Inhibits P2X1 Receptor-mediated Currents and Arterial Vasoconstriction
J. Biol. Chem., September 2, 2005; 280(35): 30705 - 30711.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
B. Hechler, S. Magnenat, M. L. Zighetti, M. U. Kassack, H. Ullmann, J.-P. Cazenave, R. Evans, M. Cattaneo, and C. Gachet
Inhibition of Platelet Functions and Thrombosis through Selective or Nonselective Inhibition of the Platelet P2 Receptors with Increasing Doses of NF449 [4,4',4'',4'''-(Carbonylbis(imino-5,1,3-benzenetriylbis-(carbonylimino)))tetrakis-benzene-1,3-disulfonic Acid Octasodium Salt]
J. Pharmacol. Exp. Ther., July 1, 2005; 314(1): 232 - 243.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2004 by the American Society for Biochemistry and Molecular Biology.